Avacincaptad pegol
Avacincaptad pegol Uses, Dosage, Side Effects, Food Interaction and all others data.
Avacincaptad pegol is under investigation in clinical trial NCT03362190 (ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)).
| Trade Name | Avacincaptad pegol |
| Generic | Avacincaptad pegol |
| Avacincaptad pegol Other Names | Avacincaptad pegol |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Avacincaptad pegol
